![](/img/cover-not-exists.png)
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572
Schiff, David, Jaeckle, Kurt A., Anderson, S. Keith, Galanis, Evanthia, Giannini, Caterina, Buckner, Jan C., Stella, Phillip, Flynn, Patrick J., Erickson, Bradley J., Schwerkoske, John F., Kaluza, VesLanguage:
english
Journal:
Cancer
DOI:
10.1002/cncr.31219
Date:
January, 2018
File:
PDF, 289 KB
english, 2018